Quipt Home Medical Corp. has 7 Schedule 13D or 13G filings on record since 2025-08-25. 2 holders' latest filing reports 5% or more of common shares, without par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Lakeview Opportunity Fund LLC | 8% | 3,465,178 | SCHEDULE 13D, 2025-11-07 | 2025-10-31 |
| Claret Asset Management Corporation | 7.33% | 3,225,309 | SCHEDULE 13G/A, 2026-02-10 | 2025-12-31 |
| Forager Fund, L.P. | 0% | 0 | SCHEDULE 13D/A, 2026-03-16 | 2026-03-16 |
| Glazer Capital, LLC | 0% | 0 | SCHEDULE 13G/A, 2026-05-14 | 2026-03-31 |
Purpose of Transaction (Item 4)
Forager Fund, L.P.
Item 4 is hereby amended and supplemented as follows: On March 16, 2026, pursuant to the Arrangement Agreement and Plan of Arrangement, the previously announced Arrangement among the Issuer, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware company (individually, "REM Aggregator," and collectively with B.C. Purchaser, "Purchaser" or "Purchasers") was completed, upon which all issued and outstanding common shares of the Issuer were acquired by Purchasers for cash consideration of $3.65 per share, without interest.Item 4 of the SCHEDULE 13D/A filed 2026-03-16
Lakeview Opportunity Fund LLC
The Reporting Persons purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.Item 4 of the SCHEDULE 13D filed 2025-11-07
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-25 | Forager Fund, L.P. | 9.7% | SCHEDULE 13D/A |
| 2025-11-07 | Lakeview Opportunity Fund LLC | 8% | SCHEDULE 13D |
| 2025-12-16 | Forager Fund, L.P. | 9.5% | SCHEDULE 13D/A |
| 2026-01-15 | Glazer Capital, LLC | 5.62% | SCHEDULE 13G |
| 2026-02-10 | Claret Asset Management Corporation | 7.33% | SCHEDULE 13G/A |
| 2026-03-16 | Forager Fund, L.P. | 0% | SCHEDULE 13D/A |
| 2026-05-14 | Glazer Capital, LLC | 0% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Quipt Home Medical Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.